Cancer clinical trials : Welcome to the ASCI studies site!
This site tells you about two clinical studies that are evaluating a potential new cancer treatment called ASCI* (Antigen-Specific Cancer Immunotherapeutics). They will look at how safe ASCI is, and how well it works. Both are currently recruiting patients to take part in the studies.
MAGRIT is a study of ASCI in patients with non-small cell lung cancer (NSCLC). It is open to patients who have had their tumor removed by an operation.
DERMA is studying ASCI in patients with melanoma who have had an operation to remove their tumor.
This site is designed for cancer patients and their families who would like to find out more about MAGRIT or DERMA. You can find out :
- What clinical stuides are and how they work
- What MAGRIT and DERMA involve
- Whether you are eligible to take part
Each study has its own pages. Use the buttons below to select the study you are interested in.
